Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice

Journal of Infectious Diseases

Volumn 193, Issue 9, 2006, Pages 1323-1331

  Fierer, Joshua ^a,b,c   Waters, Crystal ^c   Walls, Lorraine ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; COCCIDIOIDES IMMITIS VACCINE; FUNGUS VACCINE; MESSENGER RNA; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; FUNGAL STRAIN; FUNGAL VIRULENCE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; KNOCKOUT MOUSE; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; BETA 2-MICROGLOBULIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; FEMALE; FUNGAL VACCINES; IMMUNITY, CELLULAR; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 33646018966     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/502972     Document Type: Article

References (57)

1. Pappagianis D. Epidemiology of coccidioidomycosis. In: McGinnis MR, ed. Current topics in Medical Mycology. Vol 2. New York: Springer-Verlag, 1988:199-238.
2. Stevens DA. Coccidioidomycosis. N Engl J Med 1995; 332:1077-82.
3. Kong Y-CM, Levine HB, Madin SH, Smith CE. Fungal multiplication and histopathologic changes in vaccinated mice infected with Coccidioides immitis. J Immunol 1964; 92:779-90.
4. Kirkland TN, Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis 1996; 2:192-9.
5. Mardo D, Christensen RA, Nielson N, et al. Coccidioidomycosis in workers at an archeologic site-Dinosaur National Monument, Utah, June-July 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1005-8.
6. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990; 3:247-68.
7. Gray GC, Fogle EF, Albright KL. Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994. Am J Trop Med Hyg 1998; 58:309-12.
8. Johnson WM. Racial factors in coccidioidomycosis: mortality experience in Arizona. A review of the literature. Ariz Med 1982; 39:18-24.
9. Ampel NM, Dois CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94:235-40.
10. Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 1993; 48:149-56.
11. Deresinski SC, Steven DA. Coccidioidomycosis in compromised hosts. Medicine 1975; 54:377-95.
12. Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists. Arthritis Rheum 2004; 50:1959-66.
13. Barnato AE, Sanders GD, Owens DK. Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg Infect Dis 2001; 7:797-806.
14. Cole GT, Xue M, Okeke CN, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 2004; 42:189-216.
15. Pappagianis D, Levine HB. The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol 1975; 102:30-41.
16. Pappagianis D, Valley Fever Vaccine Study Group. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 1993; 148:656-60.
17. Kirkland TN, Finley F, Orsborn KI, Galgiani JN. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 1998; 66:3519-22.
18. Delgado N, Xue J, Yu J-J, Hung C-Y, Cole GT. A recombinant β-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect Immun 2003; 71:3010-9.
19. Fierer J, Chikami G, Hatlen L, Heffernan EJ, Guiney D. Active immunization with LD842, a plasmid-cured strain of Salmonella dublin, protects mice against group D and group B Salmonella infection. J Infect Dis 1988; 158:460-3.
20. Jiang C, Magee DM, Cox RA. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 1999; 67:5848-53.
21. Li K, Yu J-J, Hung C-Y, Lehmann PF, Cole GT. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice. Infect Immun 2001; 69:2878-87.
22. Drutz DJ, Catanzaro A. Coccidioidomycosis. Part I. Am Rev Respir Dis 1978; 117:559-83.
23. Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis 1982; 4:656-64.
24. Clemons KV, Leathers CR, Lee KW. Systemic Coccidioides immitis infection in nude and beige mice. Infect Immun 1985; 47:814-21.
25. Beaman L, Pappagianis D, Benjamini E. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect Immun 1977; 17:580-5.
26. Beaman L, Pappagianis D, Benjamini E. Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect Immun 1979; 23:681-5.
27. Cox RA, Magee DM. Protective immunity in coccidioidomycosis. Res Immunol 1998; 149:417-28.
28. Magee DM, Cox RA. Roles of γ interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 1995; 63:3514-9.
29. Fierer J, Walls L, Eckmann L, Yamamoto T, Kirkland TN. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect Immun 1998; 66:4397-402.
30. Cox RA, Magee DM. Production of tumor necrosis factor α, interleukin-1 α, and interleukin-6 during murine coccidioidomycosis. Infect Immun 1995; 63:4178-80.
31. Schijns VE. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000; 12:456-63.
32. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350:423-6.
33. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in β 2M MHC class I proteins, and CD8+ T cells. Science 1990; 248:1227-30.
34. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-defident mice. Nature 1994; 369:31-7.
35. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991; 353:180-4.
36. Pollock JS, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9:202-9.
37. Pfeffer K, Matsuyama T, Kundig TM, et al. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73:457-67.
38. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259:1739-42.
39. Mombaerts P, Clarke AR, Rudnicki MA, et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 1992; 360:225-31.
40. Walch HA, Kalvoda A. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines. Sabouraudia 1971; 9:173-84.
41. Kirkland TN, Fierer J. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. Infect Immun 1983; 40:912-6.
42. Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94:73-84.
43. S) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J Immunol 1996; 156:2894-900.
44. Zhan Y, Corbett AJ, Brady JL, Sutherland RM, Lew AM. Delayed rejection of fetal pig pancreas in CD4 cell deficient mice was correlated with residual helper activity. Xenotransplantation 2000; 7:267-74.
45. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165:6107-15.
46. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L, Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 1999; 162:2829-36.
47. Rocha B. Requirements for memory maintenance. Nat Immunol 2002; 3:209-10.
48. Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 t cells. J Immunol 2004; 173:4590-7.
49. + T-cell immunity against encephalitozoon cuniculi infection. Infect Immun 2000; 68:6223-32.
50. + T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 2003; 197:1405-16.
51. Delves PJ, Roitt IM. The immune system: second of two parts. N Engl J Med 2000; 343:108-17.
52. Lenz LL, Butz EA, Bevan MJ. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med 2000; 192:1135-42.
53. + T cells. J Immunol 2000; 165:915-24.
54. Wüthrich M, Filutowicz HI, Warner T, Klein BS. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 2002; 169:6969-76.
55. Magee DM, Friedberg RL, Woltaske MD, Johnston SA, Cox RA, Ábel T. Role of B cells in vaccine-induced immunity against coccidioidomycosis. Infect Immun 2005; 73:7011-3.
56. Kirkland TN, Raz E, Datta SK. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Vaccine 2006; 24:495-500.
57. Abuodeh RO, Shubitz LF, Siegel E, et al. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen. Infect Immun 1999; 67:2935-40.